OMI:NYE-Owens & Minor Inc. (USD)

EQUITY | Medical Distribution | New York Stock Exchange

Last Closing

USD 12.56

Change

+0.04 (+0.32)%

Market Cap

USD 2.07B

Volume

0.62M

Analyst Target

USD 15.88
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Owens & Minor Inc is a healthcare logistics company that connects the world of medical products to the point of care.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-23 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

-0.05 (-0.02%)

USD 44.01B
CAH Cardinal Health Inc

+0.07 (+0.06%)

USD 28.62B
MCK McKesson Corporation

-2.98 (-0.51%)

N/A
NVG Nuveen AMT Free Municipal Cred..

-0.05 (-0.41%)

N/A

ETFs Containing OMI

DFVE DoubleLine ETF Trust 0.23 % 0.00 %

-0.05 (-0.16%)

USD 0.01B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -34.82% 20% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.82% 20% F 6% D-
Trailing 12 Months  
Capital Gain -37.07% 20% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.07% 20% F 5% F
Trailing 5 Years  
Capital Gain 141.07% 80% B- 92% A
Dividend Return 0.46% 20% F 1% F
Total Return 141.54% 60% D- 91% A-
Average Annual (5 Year Horizon)  
Capital Gain 61.63% 100% F 95% A
Dividend Return 61.66% 100% F 95% A
Total Return 0.03% 20% F 3% F
Risk Return Profile  
Volatility (Standard Deviation) 167.42% 20% F 6% D-
Risk Adjusted Return 36.83% 40% F 51% F
Market Capitalization 2.07B N/A N/A N/A N/A

Key Financial Ratios

  Ratio vs. Industry/Classification (Medical Distribution) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 18.40 N/A N/A
Price/Book Ratio N/A N/A N/A
Price / Cash Flow Ratio N/A N/A N/A
Price/Free Cash Flow Ratio N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A
Return on Invested Capital N/A N/A N/A
Return on Assets N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector